This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Jan 1;31(1):11-3.

doi: 10.1200/JCO.2012.46.0410. Epub 2012 Dec 3.

On the merits and limitations of whole-brain radiation therapy

Atif J Khan, Adam P Dicker

PMID: 23213090
DOI: 10.1200/JCO.2012.46.0410

Editorial

On the merits and limitations of whole-brain radiation therapy

Atif J Khan et al. J Clin Oncol. 2013.

. 2013 Jan 1;31(1):11-3.

doi: 10.1200/JCO.2012.46.0410. Epub 2012 Dec 3.

Authors

Atif J Khan, Adam P Dicker

PMID: 23213090
DOI: 10.1200/JCO.2012.46.0410

No abstract available

PubMed Disclaimer

Comment on

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A. Soffietti R, et al. J Clin Oncol. 2013 Jan 1;31(1):65-72. doi: 10.1200/JCO.2011.41.0639. Epub 2012 Dec 3. J Clin Oncol. 2013. PMID: 23213105 Clinical Trial.

Similar articles

Does quality of life supplant survival in patients with brain metastasis?
Chamberlain MC. Chamberlain MC. J Clin Oncol. 2013 Jul 10;31(20):2635. doi: 10.1200/JCO.2013.48.9286. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733762 No abstract available.
Reply to M.C. Chamberlain and C. Gemici.
Soffietti R. Soffietti R. J Clin Oncol. 2013 Jul 10;31(20):2636-7. doi: 10.1200/JCO.2013.49.4443. J Clin Oncol. 2013. PMID: 23991432 No abstract available.
Progression-free survival benefit or health-related quality-of-life advantage: which one to choose?
Gemici C. Gemici C. J Clin Oncol. 2013 Jul 10;31(20):2635-6. doi: 10.1200/JCO.2013.49.3478. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733775 No abstract available.
[Cognition and radiation therapy for brain metastases: a new paradigm to define].
Tallet A, Dhermain F, Taillia H, Ricard D, Mornex F, Métellus P. Tallet A, et al. Bull Cancer. 2013 Jan 1;100(1):69-74. doi: 10.1684/bdc.2012.1682. Bull Cancer. 2013. PMID: 23302115 Review. French.
An update on radiation therapy for brain metastases.
Lam TC, Sahgal A, Lo SS, Chang EL. Lam TC, et al. Chin Clin Oncol. 2017 Aug;6(4):35. doi: 10.21037/cco.2017.06.02. Chin Clin Oncol. 2017. PMID: 28841797 Review.

See all similar articles

Cited by

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer.
Fang L, Zhao W, Ye B, Chen D. Fang L, et al. Front Oncol. 2021 May 4;11:670313. doi: 10.3389/fonc.2021.670313. eCollection 2021. Front Oncol. 2021. PMID: 34017689 Free PMC article. Review.
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China.
Wang Y, Lian B, Si L, Chi Z, Sheng X, Wang X, Mao L, Tang B, Li S, Yan X, Bai X, Zhou L, Cui C, Guo J. Wang Y, et al. J Cancer Res Clin Oncol. 2021 Sep;147(9):2731-2740. doi: 10.1007/s00432-021-03563-0. Epub 2021 Feb 21. J Cancer Res Clin Oncol. 2021. PMID: 33611636 Free PMC article.
Surgical Cavity Constriction and Local Progression Between Resection and Adjuvant Radiosurgery for Brain Metastases.
Shah JK, Potts MB, Sneed PK, Aghi MK, McDermott MW. Shah JK, et al. Cureus. 2016 Apr 19;8(4):e575. doi: 10.7759/cureus.575. Cureus. 2016. PMID: 27226936 Free PMC article.
Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial.
Kim MM, Parmar H, Cao Y, Pramanik P, Schipper M, Hayman J, Junck L, Mammoser A, Heth J, Carter CA, Oronsky A, Knox SJ, Caroen S, Oronsky B, Scicinski J, Lawrence TS, Lao CD. Kim MM, et al. Transl Oncol. 2016 Apr;9(2):108-113. doi: 10.1016/j.tranon.2015.12.003. Transl Oncol. 2016. PMID: 27084426 Free PMC article.
Prognostic stratification of brain metastases from hepatocellular carcinoma.
Kim KS, Kim K, Chie EK, Kim YJ, Yoon JH, Lee HS, Ha SW. Kim KS, et al. J Neurooncol. 2014 Oct;120(1):209-14. doi: 10.1007/s11060-014-1547-6. Epub 2014 Jul 23. J Neurooncol. 2014. PMID: 25052350

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information